캐나다 - 프랑스어 - Health Canada

abbvie corporation - palivizumab - poudre pour solution - 50mg - palivizumab 50mg - monoclonal antibodies

캐나다 - 프랑스어 - Health Canada

abbvie corporation - palivizumab - poudre pour solution - 100mg - palivizumab 100mg - monoclonal antibodies

캐나다 - 프랑스어 - Health Canada

novartis pharmaceuticals canada inc - omalizumab - poudre pour solution - 150mg - omalizumab 150mg - respiratory agents, miscellaneous

캐나다 - 프랑스어 - Health Canada

hoffmann-la roche limited - pertuzumab - solution - 420mg - pertuzumab 420mg - antineoplastic agents

캐나다 - 프랑스어 - Health Canada

hoffmann-la roche limited - pertuzumab; trastuzumab - solution - 420mg; 440mg - pertuzumab 420mg; trastuzumab 440mg - antineoplastic agents

캐나다 - 프랑스어 - Health Canada

astrazeneca canada inc - palivizumab - solution - 100mg - palivizumab 100mg - monoclonal antibodies

캐나다 - 프랑스어 - Health Canada

astrazeneca canada inc - palivizumab - solution - 50mg - palivizumab 50mg - monoclonal antibodies

캐나다 - 프랑스어 - Health Canada

glaxosmithkline inc - mépolizumab - poudre pour solution - 100mg - mépolizumab 100mg - immunosuppressive agents

캐나다 - 프랑스어 - Health Canada

eli lilly canada inc - ixékizumab - solution - 80mg - ixékizumab 80mg - misc. skin and mucous membrane agents

캐나다 - 프랑스어 - Health Canada

bristol-myers squibb canada - Élotuzumab - poudre pour solution - 440mg - Élotuzumab 440mg - antineoplastic agents